CRNT(CRNT)
CRNT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $365M | $390M | $388M |
| Low | $363M | $387M | $384M |
| High | $366M | $393M | $392M |
| EBITDA Avg | $22M | $24M | $24M |
| Low | $22M | $24M | $24M |
| High | $22M | $24M | $24M |
| EBIT Avg | $9M | $10M | $10M |
| Low | $9M | $10M | $10M |
| High | $9M | $10M | $10M |
| Net Income Avg | $12M | $18M | $22M |
| Low | $12M | $14M | $22M |
| High | $12M | $23M | $23M |
| EPS Avg | $0.13 | $0.21 | $0.25 |
| Low | $0.13 | $0.16 | $0.25 |
| High | $0.14 | $0.25 | $0.25 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $95M | $99M | $94M | $94M | $99M | $104M |
| Low | $94M | $98M | $93M | $93M | $98M | $103M |
| High | $95M | $100M | $95M | $95M | $100M | $105M |
| EBITDA Avg | $6M | $6M | $6M | $6M | $6M | $6M |
| Low | $6M | $6M | $6M | $6M | $6M | $6M |
| High | $6M | $6M | $6M | $6M | $6M | $6M |
| EBIT Avg | $2M | $2M | $2M | $2M | $2M | $3M |
| Low | $2M | $2M | $2M | $2M | $2M | $3M |
| High | $2M | $3M | $2M | $2M | $3M | $3M |
| Net Income Avg | $5M | $6M | $4M | $4M | $6M | $7M |
| Low | $5M | $6M | $4M | $4M | $6M | $7M |
| High | $5M | $6M | $4M | $4M | $6M | $7M |
| EPS Avg | $0.05 | $0.07 | $0.04 | $0.04 | $0.07 | $0.08 |
| Low | $0.05 | $0.07 | $0.04 | $0.04 | $0.06 | $0.08 |
| High | $0.05 | $0.07 | $0.04 | $0.05 | $0.07 | $0.08 |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 |